Is inflammatory bowel disease a risk factor for early atherosclerosis
We have convenient locations in Sun City, AZ , Phoenix, AZ , Prescott, AZ , and Buckeye, AZ , Westpark AZ, Liberty AZ, Peoria AZ, Glendale AZ, Diamond Valley AZ, Iron Springs AZ, Bumstead AZ, El Mirage AZ, and surrounding areas
2025 Advances in Malignant Schwannoma Research and Treatment As of 2025, the management of malignant peripheral nerve sheath tumors (MPNSTs)particularly those associated with Neurofibromatosis type 1 (NF1)is entering a new era, driven by genomic insights, targeted therapies, and novel clinical trial strategies
monitoring recommended in polypharmacy settings NAD+ has the clear safety advantage through human trial data across diverse populations, though long-term safety remains unestablished for both interventions